XML 25 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Total AIG Shareholders' Equity
Preferred Stock and Additional Paid-in Capital
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non- redeemable Non- controlling Interests
Balance, beginning of period at Dec. 31, 2021 [1] $ 69,034 $ 66,068 $ 485 $ 4,766 $ (51,618) $ 81,669 $ 25,695 $ 5,071 $ 2,966
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued under stock plans (83) (83)     243 (326)      
Purchase of common stock (4,370) (4,370)     (4,370)        
Net income attributable to AIG or noncontrolling interests 10,726 9,675         9,675   1,051
Dividends on preferred stock (22) (22)         (22)    
Dividends on common stock (746) (746)         (746)    
Other comprehensive loss (34,034) (31,307)           (31,307) (2,727)
Net decrease due to divestitures and acquisitions 1,626 497       (1,619)   2,116 1,129
Contributions from noncontrolling interests 22               22
Distributions to noncontrolling interests (230)               (230)
Other 190 194       208 (14)   (4)
Balance, end of period at Sep. 30, 2022 42,113 39,906 485 4,766 (55,745) 79,932 34,588 (24,120) 2,207
Balance, beginning of period at Jun. 30, 2022 47,224 45,712 485 4,766 (54,480) 81,497 32,091 (18,647) 1,512
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued under stock plans 2 2     3 (1)      
Purchase of common stock (1,268) (1,268)     (1,268)        
Net income attributable to AIG or noncontrolling interests 3,087 2,748         2,748   339
Dividends on preferred stock (7) (7)         (7)    
Dividends on common stock (240) (240)         (240)    
Other comprehensive loss (8,306) (7,589)           (7,589) (717)
Net decrease due to divestitures and acquisitions 1,626 497       (1,619)   2,116 1,129
Contributions from noncontrolling interests 17               17
Distributions to noncontrolling interests (63)               (63)
Other 41 51       55 (4)   (10)
Balance, end of period at Sep. 30, 2022 42,113 39,906 485 4,766 (55,745) 79,932 34,588 (24,120) 2,207
Balance, beginning of period at Dec. 31, 2022 43,454 40,970 485 4,766 (56,473) 79,915 34,893 (22,616) 2,484
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued under stock plans (132) (132)     241 (373)      
Purchase of common stock (1,959) (1,959)     (1,959)        
Net income attributable to AIG or noncontrolling interests 4,351 3,550         3,550   801
Dividends on preferred stock (22) (22)         (22)    
Dividends on common stock (748) (748)         (748)    
Other comprehensive loss (2,743) (1,679)           (1,679) (1,064)
Net decrease due to divestitures and acquisitions 1,127 (92)       (1,858)   1,766 1,219
Contributions from noncontrolling interests 35 (92)             35
Distributions to noncontrolling interests (317)               (317)
Other 167 96       80 16   71
Balance, end of period at Sep. 30, 2023 43,213 39,984 485 4,766 (58,191) 77,764 37,689 (22,529) 3,229
Balance, beginning of period at Jun. 30, 2023 46,491 42,454 485 4,766 (57,408) 77,677 35,916 (18,982) 4,037
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued under stock plans 8 8     11 (3)      
Purchase of common stock (794) (794)     (794)        
Net income attributable to AIG or noncontrolling interests 2,747 2,027         2,027   720
Dividends on preferred stock (7) (7)         (7)    
Dividends on common stock (254) (254)         (254)    
Other comprehensive loss (4,918) (3,486)           (3,486) (1,432)
Net decrease due to divestitures and acquisitions (48) (6)       55   (61) (42)
Contributions from noncontrolling interests 8 (6)             8
Distributions to noncontrolling interests (65)               (65)
Other 45 42       35 7   3
Balance, end of period at Sep. 30, 2023 $ 43,213 $ 39,984 $ 485 $ 4,766 $ (58,191) $ 77,764 $ 37,689 $ (22,529) $ 3,229
[1] Updated to reflect the adoption of long-duration targets improvements, see Note 2.